Dimmito Marilisa Pia, Marinelli Lisa, Toto Eleonora Chiara, Di Biase Giuseppe, Cacciatore Ivana, Toto Pierpaolo, Ciulla Michele, Monti Benedetta, Santoleri Fiorenzo, Costantini Alberto, Di Stefano Antonio
Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy;
ASL Benevento U.O.C. Assistenza Farmaceutica, Via Trieste e Trento, 82100 Benevento, Italy;
J Mark Access Health Policy. 2025 Mar 31;13(2):12. doi: 10.3390/jmahp13020012. eCollection 2025 Jun.
This work proposes a methodological approach that could be useful in multidisciplinary health technology assessments (HTAs). Mathematical models based on real data were used to make predictions for the initial price and actual cost of three classes of biological drugs. Through a comparison of real data, with the data derived through this approach, degree coefficients were formulated to rank the negotiating capabilities of Italian regions. The proposed method could represent a valid means of support for healthcare decisionmakers in planning and reducing pharmaceutical spending, evaluating data, and finding uses for particular medical technologies. This study could be a useful tool for achieving the objectives of HTAs, providing a means of analysis that can be adapted to any data, which may be useful for rationalizing the use of health technologies, reducing waste, and optimally reallocating resources.
这项工作提出了一种方法，该方法可能对多学科卫生技术评估（HTA）有用。基于真实数据的数学模型被用于预测三类生物药物的初始价格和实际成本。通过将真实数据与通过该方法得出的数据进行比较，制定了程度系数以对意大利各地区的谈判能力进行排名。所提出的方法可以成为医疗保健决策者在规划和减少药品支出、评估数据以及寻找特定医疗技术用途方面的有效支持手段。这项研究可能是实现卫生技术评估目标的有用工具，提供一种可适用于任何数据的分析方法，这对于合理使用卫生技术、减少浪费以及优化资源重新分配可能是有用的。
